Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Apoptosis meets proteasome, an invaluable therapeutic target of anticancer drugs.

The Italian journal of biochemistry - 1 Jun 2003

Giuliano Michela, D'Anneo Antonella, De Blasio Anna, Vento Renza, Tesoriere Giovanni

Abstract excerpt

This report reviews the current status of extensive efforts directed towards the interpretation of crosstalk between apoptosis and proteasome to understanding the molecular mechanism of anticancer agents targeting proteasome, with particular focus on MG132 and PS-341. The discovery that all cancer cells have retained the apoptotic death program has offered to the researchers new biochemical targets to design...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Boronic Acids
Share to Bortezomib
Share to Cysteine Endopeptidases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leupeptins

Share to Multienzyme Complexes

Share to Peptide Hydrolases

Share to Protease Inhibitors

Share to Pyrazines

Source

Identifiers

PMID: 14677428

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Apoptosis meets proteasome, an invaluable therapeutic target of anticancer drugs.PMID 14677428Read ↗

MG132, a proteasome inhibitor, induces apoptosis in tumor cellsSemantic proximity Read ↗

Proteasome as an Emerging Therapeutic Target in CancerSemantic proximity Read ↗

A boronic-chalcone derivative exhibits potent anticancer activity through inhibition of the proteasome.Semantic proximity Read ↗

Proteasome Inhibitors Induce p53-Independent Apoptosis in Human Cancer CellsSemantic proximity Read ↗

Targeting ubiquitin-proteasome pathway by natural, in particular polyphenols, anticancer agents: Lessons learned from clinical trialsSemantic proximity Read ↗

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.Semantic proximity Read ↗

The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5Semantic proximity Read ↗

Therapeutic targeting of cancer cell cycle using proteasome inhibitorsSemantic proximity Read ↗

Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancerSemantic proximity Read ↗

Investigating the mechanisms underlying Bortezomib resistanceSemantic proximity Read ↗

Identification of new compounds that trigger apoptosome-independent caspase activation and apoptosis.Semantic proximity Read ↗

Novel Organic Proteasome Inhibitors Identified by Virtual and in Vitro ScreeningSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.